Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations-Reference-Cited by-同舟云学术

Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations

Published:2020-05-20 Issue:19 Volume:63 Page:10726-10741
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lu Xiaoyun¹^ORCID,Smaill Jeff B.²,Ding Ke¹^ORCID

Affiliation:

1. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China

2. Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand

Funder

Guangdong Science and Technology Department

Ministry of Science and Technology of the People's Republic of China

Health Research Council of New Zealand

Jinan University

National Natural Science Foundation of China

Cancer Society Auckland Northland

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine